Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Emblem Receives Final Order Approving Arrangement With Aleafia TORONTO, March 08, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) is pleased to announce that it has received a final order from the Ontario Superior Court of Justice (Commercial List) approving the previously announced plan of arrangement (the “Arrangement”) with Aleafia Health Inc. (“Aleafia”) described in the joint press release issued by Emblem and Aleafia on December 19, 2018. Closing of the Arrangement remains subject to customary closing conditions, including the final app...
Emblem Corp. Shareholders Approve Proposed Arrangement with Aleafia Health, Announces Results of Special Meeting TORONTO, March 06, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) is pleased to announce that, at the special meeting of shareholders of Emblem held today (the “Meeting”), the shareholders of Emblem voted in favour of a special resolution to approve the proposed arrangement (the “Arrangement”) involving Emblem and Aleafia Health described in the joint press release issued by Emblem and Aleafia on December 19, 2018, as well as certain...
Emblem Corp. Announces Receipt of Interim Court Order and Mailing of Meeting Materials Related to its Special Meeting of Shareholders and Proposed Arrangement with Aleafia Health Inc. TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) announces that the Ontario Superior Court of Justice (Commercial List) granted the Company’s motion for an interim order authorizing various matters, including the mailing of a management information circular (the “Circular”) and the holding of the special meeting of Emblem shareholders to be held on...
Emblem Oils Now Available Through Shoppers Drug Mart TORONTO, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) through its wholly-owned subsidiary Emblem Cannabis Corporation, today announced that Emblem-branded cannabis oils are now available online through Shoppers Drug Mart to patients with a valid medical authorization. “As a patient-first provider, Emblem is committed to helping provide patients access to our products through distribution channels that provide both care and convenience like Shoppers Drug Mart,” said Nick Dean, CE...
Aleafia Health Inc. to Acquire Emblem Corp. to Create New Medical Cannabis Leader Combination will create Canada’s largest medical cannabis clinic network with access to 40 medical clinics and education centres;Aleafia patients to access Emblem’s differentiated, high margin derivative products including capsules, oils and oral sprays, along with award-winning customer service and eCommerce platform;Regulatory acceleration with Aleafia leveraging Emblem’s Health Canada License to extract and process medical cannabis products and sell them directly to patients;Aleafia to become among nationa...
Emblem launches new line of Oil Capsules Capsules are latest addition to the Company’s growing line of innovative medical cannabis products TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, today announced the launch of a new line of 10mg Emblem Oil Capsules, providing its growing list of 6,000+ patients with a pre-dosed treatment format. This convenient capsule formulation is designed to help patients better manage their treatment through precise dosing of their...
Emblem Corp. Reports Strong Third Quarter 2018 Financial Results Revenues increase 281% over the quarter ended September 30, 2017 and 50% over Q2 2018 TORONTO, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), a licensed producer of cannabis under the Cannabis Act through its wholly owned subsidiary Emblem Cannabis Corporation, is pleased to report financial and operating results for the three and nine months ended September 30, 2018. The strong results underscore the Company’s continued focus on fundamentals such as revenue grow...
Emblem Corp. announces new board appointments TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi to its Board of Directors (the “Board”) following Emblem’s annual and special shareholders’ meeting. Harvey Shapiro, current chair, and Maxim Zavet have stepped down from the Board, and the Board would like to thank them for their immense contributions since Emblem’s inception. Ms. Stefankiewicz and Mr. Grimaldi will join current Board members Daniel Milliar...
Emblem finalizes agreement to launch Emblem Germany in joint venture with Acnos Pharma Agreement will see Emblem export to one of the world’s largest legal medical cannabis markets TORONTO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) ("Emblem" or the "Company"), today announced that, through its wholly-owned subsidiary Emblem Cannabis Corporation (“ECC”), it has signed a definitive agreement with German pharmaceutical wholesaler Acnos Pharma GmbH (“Acnos”) in respect to launching a joint venture under the name “Emblem Germany” (the “JV”) for the purpose of e...
Emblem Establishes Temporary “Patient Access Investment Fund” to Partially Cover Medical Cannabis Excise Tax Emblem will continue to advocate against the application of any tax on medical cannabis TORONTO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX:) ("Emblem" or the "Company") today announced that it will segregate CDN $5 million of its current cash holdings to establish what it is calling the Patient Access Investment Fund (the “Fund”), the interest from which will be used to help offset some of the cost of the excise tax that will be applied to medical cannabis p...
A Letter from Emblem’s President & CEO TORONTO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC, OTCQX:) ("Emblem" or the "Company") delivers strategic vision to shareholders: With adult-use legalization only days away, I am incredibly excited to provide an update on Emblem’s progress and plans for the future. 2018 has been a year of enormous change and evolution for the Emblem group of companies. We have made incredible strides and I couldn’t be prouder of the team we’ve assembled. Emblem continues to bring innovative products to market, most recently with the launch of Atmos...
Emblem to supply British Columbia and Saskatchewan markets with high quality cannabis Emblem supply to reach four key provinces TORONTO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX:) (“Emblem” or the "Company") today announced that its wholly-owned subsidiary, Emblem Cannabis Corporation, one of Canada’s leading licensed producers of medical cannabis, has received approval to supply British Columbia and Saskatchewan with premium cannabis products under Emblem’s adult-use brand, Symbl. In B.C., Emblem has been approved to supply cannabis to the BC Liquor Distribution...
Emblem Bolsters Medical Division to Support Growth and Product Innovation with Appointment of Wayne Kreppner as President TORONTO, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX:) ("Emblem" or the "Company") today announced additional leadership and operational resources to support the rapid growth of its medical division and associated new product innovations. Emblem Director and current Medical Division President, John H. Stewart, welcomes Wayne Kreppner to the Company as the Division’s new President. Mr. Stewart will oversee the Division in an advisory capacity and wi...
Emblem Corp. Announces Grant of Stock Options TORONTO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) announced that the board of directors of the Company has approved the granting of 350,000 incentive stock options (the “Options”) to certain officers of the Company. The Options are exercisable at a price of $1.60 per share for a period of five years and are subject to vesting as to one-third the number of Options granted on each of September 25, 2019, 2020 and 2021. About Emblem Emblem, through its wholly-owned subsidiary Emblem Ca...
Emblem partners with DriveABLE to support research that evaluates impairment risk Evaluating impairment – both roadside and in the workplace – integral to safe communities TORONTO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) today announced it has completed an equity investment in DriveABLE Assessment Centres Inc. (“DriveABLE”), a global leader in cognitive-based driving evaluations that measure the risk of impairment. Through this investment – to Emblem’s knowledge, the first of its kind in the cannabis space – Emblem will suppo...
Emblem and Canntab to Commence Clinical Testing of 12-Hour Extended Release Cannabis Tablets TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), along with Canntab Therapeutics Limited (“Canntab”), today announced that they have achieved a milestone with regards to the development of a patent-pending oral extended release formulation for cannabinoids (the...
Emblem and Natura Naturals announce termination of letter of intent TORONTO, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), and Natura Naturals Holdings Inc. (“Natura”) announced the termination of their letter of intent as of 5 p.m. EST on September 13, 2018. “Emblem looks forward to maintaining its strong business relationship with the Natura team as both a...
Emblem launches Atmosphere, its first oral dose-metered spray Atmosphere provides patients with precise dosing and convenient delivery TORONTO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), today announced the launch of its first oral dose-metered spray, Emblem Atmosphere. Designed with patients’ needs in mind, Atmosphere ensures a precise dose with each s...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.